{"version":"1.0","provider_name":"Times South Africa","provider_url":"https:\/\/timessouthafrica.com","author_name":"TSA","author_url":"https:\/\/timessouthafrica.com\/author\/tsa\/","title":"ADQ renforce davantage son portefeuille Healthcare &amp; Pharma avec l\u2019accord d\u2019acqu\u00e9rir la soci\u00e9t\u00e9 pharmaceutique Acino - Times South Africa","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"sIaOUWv3Y6\"><a href=\"https:\/\/timessouthafrica.com\/adq-renforce-davantage-son-portefeuille-healthcare-pharma-avec-laccord-dacquerir-la-societe-pharmaceutique-acino\/\">ADQ renforce davantage son portefeuille Healthcare &amp; Pharma avec l\u2019accord d\u2019acqu\u00e9rir la soci\u00e9t\u00e9 pharmaceutique Acino<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/timessouthafrica.com\/adq-renforce-davantage-son-portefeuille-healthcare-pharma-avec-laccord-dacquerir-la-societe-pharmaceutique-acino\/embed\/#?secret=sIaOUWv3Y6\" width=\"600\" height=\"338\" title=\"&#8220;ADQ renforce davantage son portefeuille Healthcare &amp; Pharma avec l\u2019accord d\u2019acqu\u00e9rir la soci\u00e9t\u00e9 pharmaceutique Acino&#8221; &#8212; Times South Africa\" data-secret=\"sIaOUWv3Y6\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"\u2013\u00a0ADQ va acqu\u00e9rir Acino, un fabricant pharmaceutique suisse pr\u00e9sent dans plus de 90\u00a0pays. \u2013 L\u2019investissement s\u2019appuie sur l\u2019intention d\u2019ADQ de d\u00e9velopper une plateforme pharmaceutique int\u00e9gr\u00e9e comprenant des capacit\u00e9s avanc\u00e9es de d\u00e9veloppement de m\u00e9dicaments, d\u2019octroi de licences, de fabrication et de commercialisation sur des march\u00e9s de pointe s\u00e9lectionn\u00e9s. \u2013 Acino sera la plus grande acquisition d\u2019ADQ [\u2026]"}